Newborns, especially those born prematurely, often lack sufficient natural surfactant. This deficiency can lead to respiratory complications, most notably RDS. The administration of synthetic surfactants can significantly reduce the incidence and severity of these complications. By replacing or supplementing the natural surfactant, these synthetic agents help to stabilize the alveoli, improve oxygenation, and reduce the work of breathing.
